MHLDA Nursing Associates Focus Group

计划入组 10 人 · 首次发布于 2025 年 6 月 6 日

French Observational Study of Complications Associated With Anticoagulants and Antiplatelet Treatment in Retina/Vitreous Surgery

计划入组 748 人 · 首次发布于 2019 年 3 月 5 日

EVA Nexus Vitrectomy Device Field Observation Study

计划入组 250 人 · 首次发布于 2022 年 2 月 8 日

Biological isolate (United Paragon Associates)

JK-05 (Academy of Military Medical Sciences）

Ethylaminobenzylmethylcarbonyl Group

C₁₇H₂₄N₂O₃

RETINA-VITREOUS ASSOCIATES, INC.

United States

RETINA AND VITREOUS ASSOCIATES OF KENTUCKY, PLLC

United States

RETINA & VITREOUS ASSOCIATES OF ALABAMA PC

United States

Photobiomodulation Shows Promise in Treating Dry Macular Degeneration

FDA Approves Light Therapy System for Dry Age-Related Macular Degeneration

Optigo Biotherapeutics Advances Long-Acting Anti-VEGF Therapy XPK-640 Toward IND-Enabling Studies